bioRxiv ScienceSearch

Biology subjects

Braun, K. P. J.

Publications and source records attributed to Braun, K. P. J..

2 recordsLinked to original sources

The etiological classification of the epilepsies: A brain network underpinning?

Objectivethe current epilepsy classification is primarily clinical driven and lacks a mechanistic basis. A mechanistic basis of the classification, and within the classification especially the etiology layer, may help to better understand epilepsy and the associated comorbidities. It may also be helpful in guiding epilepsy treatment. With this study we aimed to investigate if there is a modelled mechanistic underpinning for the etiological epilepsy classification by assessing the association between epilepsy etiology and brain network topology. Methodsto that aim we assessed the association between epilepsy etiology and brain network topology. We included children referred to our outpatient first seizure clinic with suspected epilepsy who had a standard interictal EEG recording. From these EEGs, functional networks were constructed based on eyes-closed resting state time-series. Networks were characterized using measures of segregation, integration, centrality, and network strength. Principal component analyses were used to assess whether patients with epilepsy of similar etiology cluster together based on their functional brain network topology. Resultsin total, 228 children with epilepsy were included. Another 402 children served as control subjects. We were not able to detect a correlation between epilepsy etiology and functional brain network topology. We also did not find a difference in brain network topology between the controls and patients with epilepsy. Conclusionsour results do not support the presence of a brain network underpinning for the etiological epilepsy classification. This may support the hypothesis that brain network abnormalities in epilepsy are a result of ongoing seizure activity rather than the epilepsy etiology itself. Further in-depth analyses of network measures and longitudinal studies are needed to confirm this hypothesis.

neuroscience

NaV1.1 and NaV1.6 selective compounds reduce the behavior phenotype in a novel zebrafish model for Dravet Syndrome

Dravet syndrome is caused by dominant loss-of-function mutations in SCN1A which cause reduced activity of Nav1.1 leading to lack of neuronal inhibition. On the other hand, gain-of-function mutations in SCN8A can lead to a severe epileptic encephalopathy subtype by over activating NaV1.6 channels. These observations suggest that Nav1.1 and Nav1.6 represent two opposing sides of the neuronal balance between inhibition and activation. Here, we hypothesize that Dravet syndrome may be treated by either enhancing Nav1.1 or reducing Nav1.6 activity. To test this hypothesis we generated and characterized a novel DS zebrafish model and tested new compounds that selectively activate or inhibit the human NaV1.1 or NaV1.6 channel respectively. We used CRISPR/Cas9 to generate two separate Scn1Lab knockout lines as an alternative to previous knock-down models. Using an optimized locomotor assay, spontaneous burst movements were detected that were unique to Scn1Lab knockouts and disappear when introducing human SCN1A mRNA. Besides the behavioral phenotype, Scn1Lab knockouts show sudden, electrical discharges in the brain that indicate epileptic seizures in zebrafish. Scn1Lab knockouts showed increased sensitivity to the convulsant pentylenetetrazole and a reduction in whole organism GABA levels. Drug screenings further validated a Dravet syndrome phenotype. We tested the NaV1.1 activator AA43279 and our newly synthesized NaV1.6 inhibitors MV1369 and MV1312 in the Scn1Lab knockouts. Both type of compounds significantly reduced the number of burst movements. Our results show that selective inhibition of NaV1.6 could be just as efficient as selective activation of NaV1.1 and these approaches could prove to be novel potential treatment strategies for Dravet syndrome and other (genetic) epilepsies. Compounds tested in zebrafish however, should always be further validated in other model systems, preferably human derived.

genetics